<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36294991</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>Two-Year Follow-Up on Chemosensory Dysfunction and Adaptive Immune Response after Infection with SARS-CoV-2 in a Cohort of 44 Healthcare Workers.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1556</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life12101556</ELocationID><Abstract><AbstractText>Persistent chemosensory dysfunction (PCD) is a common symptom of long-COVID. Chemosensory dysfunction (CD) as well as SARS-CoV-2-specific antibody levels and CD8<sup>+</sup> T-cell immunity were investigated in a cohort of 44 healthcare workers up to a median of 721 days after a positive PCR test. CD was assessed using questionnaires and psychophysical screening tests. After 721 days, 11 of 44 (25%) participants reported PCD, with five describing an impaired quality of life. One participant reported hyperosmia (increased sense of smell). The risk of PCD at 721 days was higher for participants reporting qualitative changes (parosmia (altered smell), dysgeusia (altered taste), or phantosmia (hallucination of smell)) during initial infection than in those with isolated quantitative losses during the first COVID-19 infection (62.5% vs. 7.1%). The main recovery rate occurred within the first 100 days and did not continue until follow-up at 2 years. No correlation was found between antibody levels and CD, but we observed a trend of a higher percentage of T-cell responders in participants with CD. In conclusion, a significant proportion of patients suffer from PCD and impaired quality of life 2 years after initial infection. Qualitative changes in smell or taste during COVID-19 pose a higher risk for PCD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schambeck</LastName><ForeName>Sophia E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Helios Klinikum Munich West, Steinerweg 5, 81241 Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine, Technical University of Munich, Trogerstr. 30, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mateyka</LastName><ForeName>Laura M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine, Technical University of Munich, Trogerstr. 30, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burrell</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine, Technical University of Munich, Trogerstr. 30, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graf</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Virology, School of Medicine, Technical University of Munich, Trogerstr. 30, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brill</LastName><ForeName>Ioana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Helios Klinikum Munich West, Steinerweg 5, 81241 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stark</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Helios Klinikum Munich West, Steinerweg 5, 81241 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Protzer</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0002-9421-1911</Identifier><AffiliationInfo><Affiliation>Institute of Virology, School of Medicine, Technical University of Munich, Trogerstr. 30, 81675 Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Infection Research (DZIF), Partner Site Munich, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busch</LastName><ForeName>Dirk H</ForeName><Initials>DH</Initials><Identifier Source="ORCID">0000-0001-8713-093X</Identifier><AffiliationInfo><Affiliation>Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine, Technical University of Munich, Trogerstr. 30, 81675 Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Infection Research (DZIF), Partner Site Munich, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerhard</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9110-3950</Identifier><AffiliationInfo><Affiliation>Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine, Technical University of Munich, Trogerstr. 30, 81675 Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Infection Research (DZIF), Partner Site Munich, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riehl</LastName><ForeName>Henriette</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Helios Klinikum Munich West, Steinerweg 5, 81241 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poppert</LastName><ForeName>Holger</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Helios Klinikum Munich West, Steinerweg 5, 81241 Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Klinik und Poliklinik f&#xfc;r Neurologie im Neuro-Kopf-Zentrum, Klinikum rechts der Isar, Ismaninger Str. 22, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">dysgeusia</Keyword><Keyword MajorTopicYN="N">hyperosmia</Keyword><Keyword MajorTopicYN="N">immune response</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">parosmia</Keyword><Keyword MajorTopicYN="N">phantosmia</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword><Keyword MajorTopicYN="N">smell</Keyword><Keyword MajorTopicYN="N">taste</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>27</Day><Hour>1</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36294991</ArticleId><ArticleId IdType="pmc">PMC9605261</ArticleId><ArticleId IdType="doi">10.3390/life12101556</ArticleId><ArticleId IdType="pii">life12101556</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dawson P., Rabold E.M., Laws R.L., Conners E.E., Gharpure R., Yin S., Buono S.A., Dasu T., Bhattacharyya S., Westergaard R.P., et al. Loss of Taste and Smell as Distinguishing Symptoms of Coronavirus Disease 2019. Clin. Infect. Dis. 2020;72:682&#x2013;685. doi: 10.1093/cid/ciaa799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa799</ArticleId><ArticleId IdType="pmc">PMC7337666</ArticleId><ArticleId IdType="pubmed">32562541</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua A.J., Charn T.C., Chan E.C., Loh J. Acute Olfactory Loss Is Specific for COVID-19 at the Emergency Department. Ann. Emerg. Med. 2020;76:550&#x2013;551. doi: 10.1016/j.annemergmed.2020.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2020.05.015</ArticleId><ArticleId IdType="pmc">PMC7221401</ArticleId><ArticleId IdType="pubmed">32410763</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerkin R.C., Ohla K., Veldhuizen M.G., Joseph P.V., Kelly C.E., Bakke A.J., Steele K.E., Farruggia M.C., Pellegrino R., Pepino M.Y., et al. The best COVID-19 predictor is recent smell loss: A cross-sectional study. medRxiv. 2020 doi: 10.1101/2020.07.22.20157263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.22.20157263</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong D.K.C., Gendeh H.S., Thong H.K., Lum S.G., Gendeh B.S., Saim A., Salina H. A review of smell and taste dysfunction in COVID-19 patients. Med. J. Malays. 2020;75:574&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pubmed">32918429</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P., Tirelli G., Meloni P., Hopkins C., Madeddu G., De Vito A., Gardenal N., Valentinotti R., Tofanelli M., Borsetto D., et al. Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variant. Int. Forum Allergy Rhinol. 2022;12:1273&#x2013;1281. doi: 10.1002/alr.22995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22995</ArticleId><ArticleId IdType="pmc">PMC9082058</ArticleId><ArticleId IdType="pubmed">35286777</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho D.H., Reiter E.R., French E., Costanzo R.M. Decreasing Incidence of Chemosensory Changes by COVID-19 Variant. Otolaryngol. Head Neck Surg. 2022:1945998221097656. doi: 10.1177/01945998221097656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01945998221097656</ArticleId><ArticleId IdType="pmc">PMC9630171</ArticleId><ArticleId IdType="pubmed">35503739</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos R.E.A., da Silva M.G., do Monte Silva M.C.B., Barbosa D.A.M., Gomes A., Galindo L.C.M., da Silva Aragao R., Ferraz-Pereira K.N. Onset and duration of symptoms of loss of smell/taste in patients with COVID-19: A systematic review. Am. J. Otolaryngol. 2021;42:102889. doi: 10.1016/j.amjoto.2020.102889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2020.102889</ArticleId><ArticleId IdType="pmc">PMC7833280</ArticleId><ArticleId IdType="pubmed">33445036</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C., Surda P., Vaira L.A., Lechien J.R., Safarian M., Saussez S., Kumar N. Six month follow-up of self-reported loss of smell during the COVID-19 pandemic. Rhinology. 2021;59:26&#x2013;31. doi: 10.4193/Rhin20.544.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin20.544</ArticleId><ArticleId IdType="pubmed">33320115</ArticleId></ArticleIdList></Reference><Reference><Citation>Prem B., Liu D.T., Besser G., Sharma G., Dultinger L.E., Hofer S.V., Matiasczyk M.M., Renner B., Mueller C.A. Long-lasting olfactory dysfunction in COVID-19 patients. Eur. Arch. Otorhinolaryngol. 2022;279:3485&#x2013;3492. doi: 10.1007/s00405-021-07153-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-021-07153-1</ArticleId><ArticleId IdType="pmc">PMC8578909</ArticleId><ArticleId IdType="pubmed">34757458</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohla K., Veldhuizen M.G., Green T., Hannum M.E., Bakke A.J., Moein S.T., Tognetti A., Postma E.M., Pellegrino R., Hwang D.L.D., et al. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss. Rhinology. 2022 doi: 10.4193/Rhin21.415.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin21.415</ArticleId><ArticleId IdType="pmc">PMC11016179</ArticleId><ArticleId IdType="pubmed">35398877</ArticleId></ArticleIdList></Reference><Reference><Citation>Schambeck S.E., Crowell C.S., Wagner K.I., D&#x2019;Ippolito E., Burrell T., Mijocevic H., Protzer U., Busch D.H., Gerhard M., Poppert H., et al. Phantosmia, Parosmia, and Dysgeusia Are Prolonged and Late-Onset Symptoms of COVID-19. J. Clin. Med. 2021;10:5266. doi: 10.3390/jcm10225266.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10225266</ArticleId><ArticleId IdType="pmc">PMC8618742</ArticleId><ArticleId IdType="pubmed">34830550</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Gessa C., Deiana G., Salzano G., Maglitto F., Lechien J.R., Saussez S., Piombino P., Biglio A., Biglioli F., et al. The Effects of Persistent Olfactory and Gustatory Dysfunctions on Quality of Life in Long-COVID-19 Patients. Life. 2022;12:141. doi: 10.3390/life12020141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12020141</ArticleId><ArticleId IdType="pmc">PMC8878431</ArticleId><ArticleId IdType="pubmed">35207429</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P., Fabbris C., Polesel J., Emanuelli E., Tirelli G., Spinato G., Hopkins C. Two-Year Prevalence and Recovery Rate of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19. JAMA Otolaryngol. Head Neck Surg. 2022;148:889&#x2013;891. doi: 10.1001/jamaoto.2022.1983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2022.1983</ArticleId><ArticleId IdType="pmc">PMC9353700</ArticleId><ArticleId IdType="pubmed">35925596</ArticleId></ArticleIdList></Reference><Reference><Citation>Burges Watson D.L., Campbell M., Hopkins C., Smith B., Kelly C., Deary V. Altered smell and taste: Anosmia, parosmia and the impact of long COVID-19. PLoS ONE. 2021;16:e0256998. doi: 10.1371/journal.pone.0256998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0256998</ArticleId><ArticleId IdType="pmc">PMC8462678</ArticleId><ArticleId IdType="pubmed">34559820</ArticleId></ArticleIdList></Reference><Reference><Citation>Croy I., Nordin S., Hummel T. Olfactory disorders and quality of life--an updated review. Chem. Senses. 2014;39:185&#x2013;194. doi: 10.1093/chemse/bjt072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjt072</ArticleId><ArticleId IdType="pubmed">24429163</ArticleId></ArticleIdList></Reference><Reference><Citation>Frasnelli J., Hummel T. Olfactory dysfunction and daily life. Eur. Arch. Otorhinolaryngol. 2005;262:231&#x2013;235. doi: 10.1007/s00405-004-0796-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-004-0796-y</ArticleId><ArticleId IdType="pubmed">15133691</ArticleId></ArticleIdList></Reference><Reference><Citation>Veronese S., Sbarbati A. Chemosensory Systems in COVID-19: Evolution of Scientific Research. ACS Chem. Neurosci. 2021;12:813&#x2013;824. doi: 10.1021/acschemneuro.0c00788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00788</ArticleId><ArticleId IdType="pmc">PMC7885804</ArticleId><ArticleId IdType="pubmed">33559466</ArticleId></ArticleIdList></Reference><Reference><Citation>Xydakis M.S., Albers M.W., Holbrook E.H., Lyon D.M., Shih R.Y., Frasnelli J.A., Pagenstecher A., Kupke A., Enquist L.W., Perlman S. Post-viral effects of COVID-19 in the olfactory system and their implications. Lancet Neurol. 2021;20:753&#x2013;761. doi: 10.1016/S1474-4422(21)00182-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00182-4</ArticleId><ArticleId IdType="pmc">PMC8324113</ArticleId><ArticleId IdType="pubmed">34339626</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Vaira L.A., Saussez S. Prevalence and 24-month recovery of olfactory dysfunction in COVID-19 patients: A multicentre prospective study. J. Intern. Med. 2022 doi: 10.1111/joim.13564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13564</ArticleId><ArticleId IdType="pmc">PMC9538281</ArticleId><ArticleId IdType="pubmed">36000469</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P., Tofanelli M., Zanelli E., Gardenal N., Tirelli G. COVID-19-Related Quantitative and Qualitative Olfactory and Gustatory Dysfunction: Long-Term Prevalence and Recovery Rate. ORL J. Otorhinolaryngol. Relat. Spec. 2022:1&#x2013;5. doi: 10.1159/000525861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000525861</ArticleId><ArticleId IdType="pmc">PMC9747726</ArticleId><ArticleId IdType="pubmed">36063810</ArticleId></ArticleIdList></Reference><Reference><Citation>McWilliams M.P., Coelho D.H., Reiter E.R., Costanzo R.M. Recovery from COVID-19 smell loss: Two-years of follow up. Am. J. Otolaryngol. 2022;43:103607. doi: 10.1016/j.amjoto.2022.103607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2022.103607</ArticleId><ArticleId IdType="pmc">PMC9375644</ArticleId><ArticleId IdType="pubmed">35987099</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P., Hummel T., Hopkins C., Dibattista M., Menini A., Spinato G., Fabbris C., Emanuelli E., D&#x2019;Alessandro A., Marzolino R., et al. High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: A matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation. Rhinology. 2021;59:517&#x2013;527. doi: 10.4193/Rhin21.249.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin21.249</ArticleId><ArticleId IdType="pubmed">34553706</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang M.P., Staibano P., McHugh T., Sommer D.D., Snidvongs K. Self-reported olfactory and gustatory dysfunction and psychophysical testing in screening for COVID-19: A systematic review and meta-analysis. Int. Forum Allergy Rhinol. 2022;12:744&#x2013;756. doi: 10.1002/alr.22923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22923</ArticleId><ArticleId IdType="pmc">PMC8652821</ArticleId><ArticleId IdType="pubmed">34725952</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner K.I., Mateyka L.M., Jarosch S., Grass V., Weber S., Schober K., Hammel M., Burrell T., Kalali B., Poppert H., et al. Recruitment of highly cytotoxic CD8(+) T cell receptors in mild SARS-CoV-2 infection. Cell Rep. 2022;38:110214. doi: 10.1016/j.celrep.2021.110214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110214</ArticleId><ArticleId IdType="pmc">PMC8677487</ArticleId><ArticleId IdType="pubmed">34968416</ArticleId></ArticleIdList></Reference><Reference><Citation>Walliczek U., Negoias S., Hahner A., Hummel T. Assessment of Chemosensory Function Using &#x201c;Sniffin&#x2019; Sticks&#x201d;, Taste Strips, Taste Sprays, and Retronasal Olfactory Tests. Curr. Pharm. Des. 2016;22:2245&#x2013;2252. doi: 10.2174/1381612822666160216150625.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612822666160216150625</ArticleId><ArticleId IdType="pubmed">26924206</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuck B.A., Beule A., Damm M., Gudziol H., Huttenbrink K.B., Landis B.N., Renner B., Sommer J.U., Uecker F.C., Vent J., et al. Position paper &#x201c;Chemosensory testing for expert opinion in smell disorders&#x201d;. Laryngorhinootologie. 2014;93:327&#x2013;329. doi: 10.1055/s-0033-1364034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0033-1364034</ArticleId><ArticleId IdType="pubmed">24782205</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian C., Zhou M., Cheng F., Lin X., Gong Y., Xie X., Li P., Li Z., Zhang P., Liu Z., et al. Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays. Clin. Chem. Lab. Med. 2020;58:1601&#x2013;1607. doi: 10.1515/cclm-2020-0548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2020-0548</ArticleId><ArticleId IdType="pubmed">32609640</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Lawrence Erlbaum; Hillsdale, NJ, USA: 1988.</Citation></Reference><Reference><Citation>Fortunato F., Martinelli D., Iannelli G., Milazzo M., Farina U., Di Matteo G., De Nittis R., Ascatigno L., Cassano M., Lopalco P.L., et al. Self-reported olfactory and gustatory dysfunctions in COVID-19 patients: A 1-year follow-up study in Foggia district, Italy. BMC Infect. Dis. 2022;22:77. doi: 10.1186/s12879-022-07052-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07052-8</ArticleId><ArticleId IdType="pmc">PMC8783175</ArticleId><ArticleId IdType="pubmed">35065619</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Journe F., Hans S., Chiesa-Estomba C.M., Mustin V., Beckers E., Vaira L.A., De Riu G., Hopkins C., Saussez S. Severity of Anosmia as an Early Symptom of COVID-19 Infection May Predict Lasting Loss of Smell. Front. Med. 2020;7:582802. doi: 10.3389/fmed.2020.582802.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.582802</ArticleId><ArticleId IdType="pmc">PMC7732577</ArticleId><ArticleId IdType="pubmed">33330539</ArticleId></ArticleIdList></Reference><Reference><Citation>Saussez S., Sharma S., Thiriard A., Olislagers V., Vu Duc I., Le Bon S.D., Khalife M., Hans S., De Riu G., Hopkins C., et al. Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction. Eur. J. Neurol. 2021;28:3702&#x2013;3711. doi: 10.1111/ene.14994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14994</ArticleId><ArticleId IdType="pmc">PMC8444937</ArticleId><ArticleId IdType="pubmed">34157187</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan B.K.J., Han R., Zhao J.J., Tan N.K.W., Quah E.S.H., Tan C.J., Chan Y.H., Teo N.W.Y., Charn T.C., See A., et al. Prognosis and persistence of smell and taste dysfunction in patients with COVID-19: Meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022;378:e069503. doi: 10.1136/bmj-2021-069503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069503</ArticleId><ArticleId IdType="pmc">PMC9326326</ArticleId><ArticleId IdType="pubmed">35896188</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez I.J., Molinari G., Federici G., Silvestri M., De Corso E., Presutti L., Alicandri-Ciufelli M., Lucidi D. Delayed recovery from severe acute respiratory syndrome coronavirus-2 related anosmia predicts incomplete olfactory restoration. J. Laryngol. Otol. 2022;136:237&#x2013;242. doi: 10.1017/S0022215121004047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215121004047</ArticleId><ArticleId IdType="pubmed">34895368</ArticleId></ArticleIdList></Reference><Reference><Citation>Almutairi D.M., Almalki A.H., Mirza A.A., Khalifah M.J., Aljefri A.A., Alsalmi K.A., Al-Thaqafy M.S., Algarni M.A. Patterns of self-reported recovery from chemosensory dysfunction following SARS-CoV-2 infection: Insights after 1 year of the pandemic. Acta Otolaryngol. 2022;142:333&#x2013;339. doi: 10.1080/00016489.2022.2062047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016489.2022.2062047</ArticleId><ArticleId IdType="pubmed">35621146</ArticleId></ArticleIdList></Reference><Reference><Citation>Amadu A.M., Vaira L.A., Lechien J.R., Scaglione M., Saba L., Lampus M.L., Profili S.G., Le Bon S.D., Salzano G., Maglitto F., et al. Analysis of the correlations between the severity of lung involvement and olfactory psychophysical scores in coronavirus disease 2019 (COVID-19) patients. Int. Forum Allergy Rhinol. 2022;12:103&#x2013;107. doi: 10.1002/alr.22869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22869</ArticleId><ArticleId IdType="pmc">PMC8426857</ArticleId><ArticleId IdType="pubmed">34296541</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., De Vito A., Deiana G., Pes C., Giovanditto F., Fiore V., Lechien J.R., Le Bon S.D., Saussez S., Madeddu G., et al. Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: A preliminary study. Eur. Arch. Otorhinolaryngol. 2022;279:811&#x2013;816. doi: 10.1007/s00405-021-06868-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-021-06868-5</ArticleId><ArticleId IdType="pmc">PMC8117453</ArticleId><ArticleId IdType="pubmed">33983525</ArticleId></ArticleIdList></Reference><Reference><Citation>Reden J., Maroldt H., Fritz A., Zahnert T., Hummel T. A study on the prognostic significance of qualitative olfactory dysfunction. Eur. Arch. Otorhinolaryngol. 2007;264:139&#x2013;144. doi: 10.1007/s00405-006-0157-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-006-0157-0</ArticleId><ArticleId IdType="pubmed">17006637</ArticleId></ArticleIdList></Reference><Reference><Citation>Puri B.K., Monro J.A., Julu P.O., Kingston M.C., Shah M. Hyperosmia in Lyme disease. Arq. Neuropsiquiatr. 2014;72:596&#x2013;597. doi: 10.1590/0004-282X20140109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282X20140109</ArticleId><ArticleId IdType="pubmed">25098475</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stadio A., D&#x2019;Ascanio L., De Luca P., Roccamatisi D., La Mantia I., Brenner M.J. Hyperosmia after COVID-19: Hedonic perception or hypersensitivity? Eur. Rev. Med. Pharmacol. Sci. 2022;26:2196&#x2013;2200. doi: 10.26355/eurrev_202203_28368.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202203_28368</ArticleId><ArticleId IdType="pubmed">35363370</ArticleId></ArticleIdList></Reference><Reference><Citation>Marmura M.J., Monteith T.S., Anjum W., Doty R.L., Hegarty S.E., Keith S.W. Olfactory function in migraine both during and between attacks. Cephalalgia. 2014;34:977&#x2013;985. doi: 10.1177/0333102414527014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102414527014</ArticleId><ArticleId IdType="pubmed">24646836</ArticleId></ArticleIdList></Reference><Reference><Citation>Sezille C., Fournel A., Rouby C., Rinck F., Bensafi M. Hedonic appreciation and verbal description of pleasant and unpleasant odors in untrained, trainee cooks, flavorists, and perfumers. Front. Psychol. 2014;5:12. doi: 10.3389/fpsyg.2014.00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2014.00012</ArticleId><ArticleId IdType="pmc">PMC3900918</ArticleId><ArticleId IdType="pubmed">24478743</ArticleId></ArticleIdList></Reference><Reference><Citation>Agyeman A.A., Chin K.L., Landersdorfer C.B., Liew D., Ofori-Asenso R. Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis. Mayo Clin. Proc. 2020;95:1621&#x2013;1631. doi: 10.1016/j.mayocp.2020.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.05.030</ArticleId><ArticleId IdType="pmc">PMC7275152</ArticleId><ArticleId IdType="pubmed">32753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitcroft K.L., Hummel T. Olfactory Dysfunction in COVID-19: Diagnosis and Management. JAMA. 2020;323:2512&#x2013;2514. doi: 10.1001/jama.2020.8391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.8391</ArticleId><ArticleId IdType="pubmed">32432682</ArticleId></ArticleIdList></Reference><Reference><Citation>Ta N.H., Gao J., Philpott C. A systematic review to examine the relationship between objective and patient-reported outcome measures in sinonasal disorders: Recommendations for use in research and clinical practice. Int. Forum Allergy Rhinol. 2021;11:910&#x2013;923. doi: 10.1002/alr.22744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22744</ArticleId><ArticleId IdType="pmc">PMC8248036</ArticleId><ArticleId IdType="pubmed">33417297</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan H.J., Seiden A.M. Long-term follow-up of olfactory loss secondary to head trauma and upper respiratory tract infection. Arch. Otolaryngol. Head Neck Surg. 1995;121:1183&#x2013;1187. doi: 10.1001/archotol.1995.01890100087015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archotol.1995.01890100087015</ArticleId><ArticleId IdType="pubmed">7546588</ArticleId></ArticleIdList></Reference><Reference><Citation>Rank A., Tzortzini A., Kling E., Schmid C., Claus R., Loll E., Burger R., Rommele C., Dhillon C., Muller K., et al. One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms. J. Clin. Med. 2021;10:3305. doi: 10.3390/jcm10153305.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10153305</ArticleId><ArticleId IdType="pmc">PMC8347559</ArticleId><ArticleId IdType="pubmed">34362088</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Hopkins C., Sandison A., Manca A., Machouchas N., Turilli D., Lechien J.R., Barillari M.R., Salzano G., Cossu A., et al. Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia. J. Laryngol. Otol. 2020;134:1123&#x2013;1127. doi: 10.1017/S0022215120002455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215120002455</ArticleId><ArticleId IdType="pmc">PMC7729153</ArticleId><ArticleId IdType="pubmed">33190655</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehgani-Mobaraki P., Zaidi A.K., Yadav N., Floridi A., Floridi E. Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection. Clin. Immunol. 2021;230:108814. doi: 10.1016/j.clim.2021.108814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2021.108814</ArticleId><ArticleId IdType="pmc">PMC8325385</ArticleId><ArticleId IdType="pubmed">34343708</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H., Camilleri D., Garitaonandia I., Djumanov D., Chen T., Lorch U., Taubel J., Wang D. Kinetics of anti-SARS-CoV-2 IgG antibody levels and potential influential factors in subjects with COVID-19: A 11-month follow-up study. Diagn. Microbiol. Infect. Dis. 2021;101:115537. doi: 10.1016/j.diagmicrobio.2021.115537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2021.115537</ArticleId><ArticleId IdType="pmc">PMC8428032</ArticleId><ArticleId IdType="pubmed">34619569</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Diallo A.O., Dachy B., Le Bon S.D., Maniaci A., Vaira L.A., Saussez S. COVID-19: Post-vaccine Smell and Taste Disorders: Report of 6 Cases. Ear Nose Throat J. 2021:1455613211033125. doi: 10.1177/01455613211033125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01455613211033125</ArticleId><ArticleId IdType="pubmed">34467793</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell M.W., Moldoveanu Z., Ogra P.L., Mestecky J. Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection. Front. Immunol. 2020;11:611337. doi: 10.3389/fimmu.2020.611337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.611337</ArticleId><ArticleId IdType="pmc">PMC7733922</ArticleId><ArticleId IdType="pubmed">33329607</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh-Mohamed S., Sanders E.C., Gommerman J.L., Tal M.C. Guardians of the oral and nasopharyngeal galaxy: IgA and protection against SARS-CoV-2 infection. Immunol. Rev. 2022;309:75&#x2013;85. doi: 10.1111/imr.13118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.13118</ArticleId><ArticleId IdType="pmc">PMC9349649</ArticleId><ArticleId IdType="pubmed">35815463</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheatley A.K., Juno J.A., Wang J.J., Selva K.J., Reynaldi A., Tan H.X., Lee W.S., Wragg K.M., Kelly H.G., Esterbauer R., et al. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat. Commun. 2021;12:1162. doi: 10.1038/s41467-021-21444-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21444-5</ArticleId><ArticleId IdType="pmc">PMC7896046</ArticleId><ArticleId IdType="pubmed">33608522</ArticleId></ArticleIdList></Reference><Reference><Citation>Laura L., Dalmatin-Dragisic M., Martinovic K., Tutis B., Herceg I., Arapovic M., Arapovic J. Does pre-existing immunity determine the course of SARS-CoV-2 infection in health-care workers? Single-center experience. Infection. 2022:1&#x2013;8. doi: 10.1007/s15010-022-01859-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01859-y</ArticleId><ArticleId IdType="pmc">PMC9189619</ArticleId><ArticleId IdType="pubmed">35696057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewer K.J., Barrett J.R., Belij-Rammerstorfer S., Sharpe H., Makinson R., Morter R., Flaxman A., Wright D., Bellamy D., Bittaye M., et al. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nat. Med. 2021;27:270&#x2013;278. doi: 10.1038/s41591-020-01194-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01194-5</ArticleId><ArticleId IdType="pubmed">33335323</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., Vaira L.A., Saussez S., Hans S. COVID-19 Reinfection and Second Episodes of Olfactory and Gustatory Dysfunctions: Report of First Cases. Ear Nose Throat J. 2020:145561320970105. doi: 10.1177/0145561320970105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0145561320970105</ArticleId><ArticleId IdType="pubmed">33170036</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., Radulesco T., Michel J., Vaira L.A., Le Bon S.D., Horoi M., Falanga C., Barillari M.R., Hans S., et al. Clinical features of patients who had two COVID-19 episodes: A European multicentre case series. J. Intern. Med. 2021;290:421&#x2013;429. doi: 10.1111/joim.13259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13259</ArticleId><ArticleId IdType="pmc">PMC8013656</ArticleId><ArticleId IdType="pubmed">33527495</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xf6;chentlicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19) 14.04.2022&#x2014;AKTUALISIERTER STAND F&#xdc;R DEUTSCHLAND.  [(accessed on 22 July 2022)].  Available online:  https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenbericht_2022-04-14.pdf?__blob=publicationFile.</Citation></Reference><Reference><Citation>W&#xf6;chentlicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19) 21.07.2022&#x2014;AKTUALISIERTER STAND F&#xdc;R DEUTSCHLAND.  [(accessed on 25 July 2022)].  Available online:  https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenbericht_2022-07-21.pdf?__blob=publicationFile.</Citation></Reference><Reference><Citation>Brandal L.T., MacDonald E., Veneti L., Ravlo T., Lange H., Naseer U., Feruglio S., Bragstad K., Hungnes O., Odeskaug L.E., et al. Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021. Euro Surveill. 2021;26:2101147. doi: 10.2807/1560-7917.ES.2021.26.50.2101147.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.50.2101147</ArticleId><ArticleId IdType="pmc">PMC8728491</ArticleId><ArticleId IdType="pubmed">34915975</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng B., Abdullahi A., Ferreira I., Goonawardane N., Saito A., Kimura I., Yamasoba D., Gerber P.P., Fatihi S., Rathore S., et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. 2022;603:706&#x2013;714. doi: 10.1038/s41586-022-04474-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04474-x</ArticleId><ArticleId IdType="pmc">PMC8942856</ArticleId><ArticleId IdType="pubmed">35104837</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Sevilla J.J., Guerri-Fernadez R., Bertran Recasens B. Is There Less Alteration of Smell Sensation in Patients With Omicron SARS-CoV-2 Variant Infection? Front. Med. 2022;9:852998. doi: 10.3389/fmed.2022.852998.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.852998</ArticleId><ArticleId IdType="pmc">PMC9039252</ArticleId><ArticleId IdType="pubmed">35492353</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitale-Cross L., Szalayova I., Scoggins A., Palkovits M., Mezey E. SARS-CoV-2 entry sites are present in all structural elements of the human glossopharyngeal and vagal nerves: Clinical implications. EBioMedicine. 2022;78:103981. doi: 10.1016/j.ebiom.2022.103981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103981</ArticleId><ArticleId IdType="pmc">PMC8978584</ArticleId><ArticleId IdType="pubmed">35390636</ArticleId></ArticleIdList></Reference><Reference><Citation>Speth M.M., Singer-Cornelius T., Oberle M., Gengler I., Brockmeier S.J., Sedaghat A.R. Mood, Anxiety and Olfactory Dysfunction in COVID-19: Evidence of Central Nervous System Involvement? Laryngoscope. 2020;130:2520&#x2013;2525. doi: 10.1002/lary.28964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.28964</ArticleId><ArticleId IdType="pmc">PMC7361512</ArticleId><ArticleId IdType="pubmed">32617983</ArticleId></ArticleIdList></Reference><Reference><Citation>Croy I., Symmank A., Schellong J., Hummel C., Gerber J., Joraschky P., Hummel T. Olfaction as a marker for depression in humans. J. Affect. Disord. 2014;160:80&#x2013;86. doi: 10.1016/j.jad.2013.12.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2013.12.026</ArticleId><ArticleId IdType="pubmed">24445134</ArticleId></ArticleIdList></Reference><Reference><Citation>Yom-Tov E., Lekkas D., Jacobson N.C. Association of COVID19-induced anosmia and ageusia with depression and suicidal ideation. J. Affect. Disord. Rep. 2021;5:100156. doi: 10.1016/j.jadr.2021.100156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jadr.2021.100156</ArticleId><ArticleId IdType="pmc">PMC8154197</ArticleId><ArticleId IdType="pubmed">34075369</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavazzana A., Larsson M., Munch M., Hahner A., Hummel T. Postinfectious olfactory loss: A retrospective study on 791 patients. Laryngoscope. 2018;128:10&#x2013;15. doi: 10.1002/lary.26606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.26606</ArticleId><ArticleId IdType="pubmed">28556265</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollndorfer K., Kowalczyk K., Hoche E., Mueller C.A., Pollak M., Trattnig S., Schopf V. Recovery of olfactory function induces neuroplasticity effects in patients with smell loss. Neural Plast. 2014;2014:140419. doi: 10.1155/2014/140419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/140419</ArticleId><ArticleId IdType="pmc">PMC4269319</ArticleId><ArticleId IdType="pubmed">25544900</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T., Rissom K., Reden J., Hahner A., Weidenbecher M., Huttenbrink K.B. Effects of olfactory training in patients with olfactory loss. Laryngoscope. 2009;119:496&#x2013;499. doi: 10.1002/lary.20101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.20101</ArticleId><ArticleId IdType="pubmed">19235739</ArticleId></ArticleIdList></Reference><Reference><Citation>Damm M., Pikart L.K., Reimann H., Burkert S., Goktas O., Haxel B., Frey S., Charalampakis I., Beule A., Renner B., et al. Olfactory training is helpful in postinfectious olfactory loss: A randomized, controlled, multicenter study. Laryngoscope. 2014;124:826&#x2013;831. doi: 10.1002/lary.24340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.24340</ArticleId><ArticleId IdType="pubmed">23929687</ArticleId></ArticleIdList></Reference><Reference><Citation>Geissler K., Reimann H., Gudziol H., Bitter T., Guntinas-Lichius O. Olfactory training for patients with olfactory loss after upper respiratory tract infections. Eur. Arch. Otorhinolaryngol. 2014;271:1557&#x2013;1562. doi: 10.1007/s00405-013-2747-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-013-2747-y</ArticleId><ArticleId IdType="pubmed">24096819</ArticleId></ArticleIdList></Reference><Reference><Citation>Pires I.A.T., Steffens S.T., Mocelin A.G., Shibukawa D.E., Leahy L., Saito F.L., Amadeu N.T., Lopes N.M.D., Garcia E.C.D., Albanese M.L., et al. Intensive Olfactory Training in Post-COVID-19 Patients: A Multicenter Randomized Clinical Trial. Am. J. Rhinol. Allergy. 2022:19458924221113124. doi: 10.1177/19458924221113124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/19458924221113124</ArticleId><ArticleId IdType="pmc">PMC9309586</ArticleId><ArticleId IdType="pubmed">35866202</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasconcelos C.C.F., Hammerle M.B., Sales D.S., Rueda Lopes F.C., Pinheiro P.G., Gouvea E.G., Alves M., Pereira T.V., Schmidt S.L., Alvarenga R.M.P., et al. Post-COVID-19 olfactory dysfunction: Carbamazepine as a treatment option in a series of cases. J. Neurovirol. 2022;28:312&#x2013;318. doi: 10.1007/s13365-022-01066-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-022-01066-3</ArticleId><ArticleId IdType="pmc">PMC8976535</ArticleId><ArticleId IdType="pubmed">35366736</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>